148 related articles for article (PubMed ID: 32657703)
21. HIV and anal cancer outcomes: a single institution's experience.
Hogg ME; Popowich DA; Wang EC; Kiel KD; Stryker SJ; Halverson AL
Dis Colon Rectum; 2009 May; 52(5):891-7. PubMed ID: 19502853
[TBL] [Abstract][Full Text] [Related]
22. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.
Kim JH; Sarani B; Orkin BA; Young HA; White J; Tannebaum I; Stein S; Bennett B
Dis Colon Rectum; 2001 Oct; 44(10):1496-502. PubMed ID: 11598480
[TBL] [Abstract][Full Text] [Related]
23. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
24. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and risk factors for anal squamous intraepithelial lesions in women.
Holly EA; Ralston ML; Darragh TM; Greenblatt RM; Jay N; Palefsky JM
J Natl Cancer Inst; 2001 Jun; 93(11):843-9. PubMed ID: 11390533
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men.
Sendagorta E; Herranz P; Guadalajara H; Bernardino JI; Viguer JM; Beato MJ; García-Olmo D; Peña JM
Dis Colon Rectum; 2014 Apr; 57(4):475-81. PubMed ID: 24608304
[TBL] [Abstract][Full Text] [Related]
27. Optimal management of squamous cell carcinoma of the anal canal: where are we now?
Eng C; Ahmed S
Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
29. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
30. Anal cancer: an overview.
Uronis HE; Bendell JC
Oncologist; 2007 May; 12(5):524-34. PubMed ID: 17522240
[TBL] [Abstract][Full Text] [Related]
31. Local excision and treatment of early node-negative anal squamous cell carcinomas in a highly HIV prevalent population.
Brogden DRL; Kontovounisios C; Chong I; Tait D; Warren OJ; Bower M; Tekkis P; Mills SC
Tech Coloproctol; 2021 Sep; 25(9):1027-1036. PubMed ID: 34117969
[TBL] [Abstract][Full Text] [Related]
32. The influence of HIV status on the duration of chemoradiotherapy for anal squamous cell carcinoma.
Zubi AR; Surridge DJ
S Afr J Surg; 2022 Mar; 60(1):16-21. PubMed ID: 35451264
[TBL] [Abstract][Full Text] [Related]
33. [Definitive treatment of anal canal carcinoma with radiotherapy: adverse impact of a pre-radiation resection. A retrospective study of 57 patients treated with curative intent].
Coquard R; Cenni JC; Artru P; Chalabreysse P; Queneau PE; Taieb S; Alessio A; Lledo G
Cancer Radiother; 2009 Dec; 13(8):715-20. PubMed ID: 19854092
[TBL] [Abstract][Full Text] [Related]
34. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.
Hauerstock D; Ennis RD; Grossbard M; Evans A
Clin Colorectal Cancer; 2010 Oct; 9(4):238-42. PubMed ID: 20920996
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity and HIV infection in patients with anal squamous-cell carcinoma.
Gervaz P; Efron J; Poza AA; Chun SW; Pham TT; Woodhouse S; Wexner SD; Carethers JM
Dis Colon Rectum; 2001 Oct; 44(10):1503-8. PubMed ID: 11598481
[TBL] [Abstract][Full Text] [Related]
37. Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients.
Abramowitz L; Mathieu N; Roudot-Thoraval F; Lemarchand N; Bauer P; Hennequin C; Mitry E; Romelaer C; Aparicio T; Sobhani I
Aliment Pharmacol Ther; 2009 Aug; 30(4):414-21. PubMed ID: 19392867
[TBL] [Abstract][Full Text] [Related]
38. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
[TBL] [Abstract][Full Text] [Related]
39. Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey.
Esin E; Yıldız F; Laçin Ş; Karakaş Y; Gültekin M; Dizdar Ö; Yalçın Ş
Turk J Gastroenterol; 2018 Jul; 29(4):411-418. PubMed ID: 30249555
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
